Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 170,992 | 150,042 | 121,463 | 118,766 | 104,762 |
| Cost of Goods | 11,912 | 13,448 | 9,789 | 10,514 | 8,437 |
| Gross Profit | 159,080 | 136,594 | 111,674 | 108,252 | 96,325 |
| Operating Expenses | 206,101 | 173,756 | 169,445 | 181,383 | 159,386 |
| Operating Income | -46,109 | -36,714 | -56,982 | -72,617 | -62,624 |
| Interest Expense | 1,120 | 1,834 | 2,431 | 2,210 | 1,978 |
| Other Income | 0 | -10,385 | 0 | 0 | 0 |
| Pre-tax Income | -47,229 | -48,933 | -59,413 | -74,827 | -64,602 |
| Income Tax | N/A | -960 | N/A | N/A | N/A |
| Net Income Continuous | -47,229 | -47,973 | -59,413 | -74,912 | -64,602 |
| Net Income | $-47,229 | $-47,973 | $-59,413 | $-74,912 | $-64,602 |
| EPS Basic Total Ops | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 |
| EPS Basic Continuous Ops | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 |
| EPS Diluted Total Ops | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 |
| EPS Diluted Continuous Ops | -0.94 | -0.97 | -1.22 | -1.54 | -1.34 |
| EPS Diluted Before Non-Recurring Items | -0.94 | -0.92 | -0.80 | -0.96 | -1.34 |
| EBITDA(a) | $-43,540 | $-34,151 | $-54,182 | $-69,836 | $-59,891 |